Bridging the Researcher-Patient Gap

Boruzu, an injectable presentation of Velcade, has been approved by the FDA for patients who either have multiple myeloma or mantle cell lymphoma.

From FDA concerns to a potential new drug, CAR-T cell therapies were dominating oncology headlines last week.

CAR-T cell therapy is moving to earlier lines of multiple myeloma treatment.

In this episode of the “Cancer Horizons” podcast, a physician assistant recalls his experience as a frontline health care worker during the COVID-19 pandemic and what it was like to get diagnosed with multiple myeloma during such a chaotic time.

Patients with multiple myeloma now have several available treatment options, so it’s important to have answers to some of the frequently asked questions.

I was diagnosed with stage 1 multiple myeloma in 2018 and writing poetry helped me work through feelings of anger and acceptance.